These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2231792

  • 1. Mutagenicity tests of mofezolac (N-22).
    Ohuchida A, Furukawa A.
    J Toxicol Sci; 1990 Jun; 15 Suppl 2():239-51. PubMed ID: 2231792
    [Abstract] [Full Text] [Related]

  • 2. Mutagenicity tests on propiverine hydrochloride.
    Ohuchida A, Furukawa A.
    J Toxicol Sci; 1989 May; 14(2):131-41. PubMed ID: 2778853
    [Abstract] [Full Text] [Related]

  • 3. [Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
    Ohuchida A, Kouchi Y, Sato S, Maeda Y.
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():675-89. PubMed ID: 9021668
    [Abstract] [Full Text] [Related]

  • 4. Mutagenicity test of cefodizime sodium.
    Ohuchida A, Yoshida R.
    J Toxicol Sci; 1988 Jun; 13 Suppl 1():245-56. PubMed ID: 3050144
    [Abstract] [Full Text] [Related]

  • 5. [Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    Ohuchida A, Taniguti A, Kouchi Y, Maeda Y, Kashihara A, Omae S.
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():263-80. PubMed ID: 7830291
    [Abstract] [Full Text] [Related]

  • 6. [Mutagenicity studies of lactitol (NS-4)].
    Iwakura K, Tamura H, Watanabe M, Sumi N.
    J Toxicol Sci; 1994 Nov; 19 Suppl 3():487-97. PubMed ID: 7837301
    [Abstract] [Full Text] [Related]

  • 7. Genotoxicity assessment of pirmenol, a new antiarrhythmic drug.
    Ciaravino V, Kropko ML, Krishna G, Monteith DK, Theiss JC.
    Mutat Res; 1992 Nov; 280(3):205-14. PubMed ID: 1381484
    [Abstract] [Full Text] [Related]

  • 8. [Mutagenicity tests of suplatast tosilate (IPD-1151T)].
    Ohuchida A, Furukawa A, Sato S, Maeda Y, Kashihara A, Mizumoto T, Yoshida R.
    J Toxicol Sci; 1992 May; 17 Suppl 2():207-20. PubMed ID: 1321262
    [Abstract] [Full Text] [Related]

  • 9. [Mutagenicity studies of prulifloxacin (NM441) and the active metabolite (NM394)].
    Iwakura K, Tamura H, Yamashita Y, Watanabe M, Sumi N, Shindo Y, Ando M, Kojima M.
    J Toxicol Sci; 1996 Jun; 21 Suppl 1():241-57. PubMed ID: 8709165
    [Abstract] [Full Text] [Related]

  • 10. [A mutagenicity study of calcipotriol (MC903)].
    Kitagaki T, Oguma Y, Yokota F, Ono M, Shirakawa K, Nagata M, Konishi R.
    J Toxicol Sci; 1996 Jul; 21 Suppl 2():465-74. PubMed ID: 8741426
    [Abstract] [Full Text] [Related]

  • 11. [Reverse mutation test of trandolapril (RU44570) with bacteria].
    Aruga F, Nagasawa Y, Tanaka R, Ishihara R.
    J Toxicol Sci; 1993 Feb; 18 Suppl 1():177-81. PubMed ID: 8515502
    [Abstract] [Full Text] [Related]

  • 12. Microbial mutagenicity and in vitro chromosome aberration induction by FK973, a new antitumor agent.
    Hirai O, Miyamae Y, Hattori Y, Takashima M, Miyamoto A, Zaizen K, Mine Y.
    Mutat Res; 1994 Jun; 324(1-2):43-50. PubMed ID: 7515469
    [Abstract] [Full Text] [Related]

  • 13. [Genotoxicity studies of cefmatilen hydrochloride hydrate (S-1090)].
    Kondo K, Takase S, Nishimoto Y, Miyajima H, Shiratori O, Miyake Y.
    J Toxicol Sci; 2001 May; 26 Suppl 1():243-54. PubMed ID: 11400316
    [Abstract] [Full Text] [Related]

  • 14. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A, Kamigaito N, Sasaki T, Matsushima T.
    Environ Mol Mutagen; 2004 May; 43(2):128-33. PubMed ID: 14991753
    [Abstract] [Full Text] [Related]

  • 15. [Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
    Tamura H, Yamashita Y, Kitayama E, Iwakura K, Watanabe M, Sumi N.
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():263-74. PubMed ID: 9170614
    [Abstract] [Full Text] [Related]

  • 16. Genotoxicity evaluation of Hwanglyeonhaedok-tang, an herbal formula.
    Jin SE, Lee MY, Seo CS, Ha H, Kim JY, Shin HK.
    J Ethnopharmacol; 2017 Apr 18; 202():122-126. PubMed ID: 27916588
    [Abstract] [Full Text] [Related]

  • 17. [Mutagenicity studies of prednisolone farnesylate (PNF)].
    Otsuka M, Ajimi S, Kajiwara Y, Ogura S, Kakimoto K, Inai T, Tanaka H, Ohuchida A.
    J Toxicol Sci; 1992 Nov 18; 17 Suppl 3():269-81. PubMed ID: 1293327
    [Abstract] [Full Text] [Related]

  • 18. [Mutagenicity studies of magnesium sulfate--reverse mutation test with bacteria and chromosomal aberration test with mammalian cells in culture].
    Oguma Y, Yokota F, Inoue K, Shimamura K.
    J Toxicol Sci; 1998 May 18; 23 Suppl 1():81-90. PubMed ID: 9617738
    [Abstract] [Full Text] [Related]

  • 19. The genotoxicity profile of atorvastatin, a new drug in the treatment of hypercholesterolemia.
    Ciaravino V, Kropko ML, Rothwell CE, Hovey CA, Theiss JC.
    Mutat Res; 1995 Jun 18; 343(2-3):95-107. PubMed ID: 7791813
    [Abstract] [Full Text] [Related]

  • 20. [Mutagenicity studies of (+/-)-4-diethylamino-1,1,-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
    Otsuka M, Kajiwara Y, Ajimi S, Shimazaki H, Kikuno T, Ogura S, Inai T, Kakimoto K, Tamura H, Watanabe M, Sumi N.
    J Toxicol Sci; 1997 Apr 18; 22 Suppl 1():251-61. PubMed ID: 9170613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.